Penserra Capital Management LLC Surrozen, Inc. Transaction History

Penserra Capital Management LLC

  • $7.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.14 - $3.43 $3,023 - $4,846
-1,413 Reduced 19.8%
5,722 $16,000
Q1 2022

May 13, 2022
BUY
$2.2 - $6.01 $5,825 - $15,914
2,648 Added 59.01%
7,135 $21,000
Q4 2021

Feb 15, 2022
BUY
$6.0 - $9.92 $26,922 - $44,511
4,487 New
4,487 $28,000

Others Institutions Holding SRZN

# of Institutions
3
Shares Held
4.52M
Call Options Held
0
Put Options Held
0
View Full List

About Surrozen, Inc.

SRZN Quotes by TradingView
  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $342M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email